SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Access to cancer medications in low- and middle-income countries
14 references·1 citing·45 second hop
Access to cancer medications in low- and middle-income countries (2013)Access to cancer medications in low- and …Systematic review and meta-analysis (2019)Systematic review and meta-an…Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003–12 (2013)Performance-based financing a…The Economics of Public Health Care Reform in Advanced and Emerging Economies (2012)The Economics of Public Healt…Primary health care: Now more than ever (2012)Primary health care: Now more…The political economy of universal health coverage. Background paper for the global symposium on health systems research (2011)The political economy of univ…Physician Perceptions About Generic Drugs (2011)Physician Perceptions About G…Bending the Cost Curve in Cancer Care (2011)Bending the Cost Curve in Can…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Global Fund To Fight AIDS, Tuberculosis, And Malaria (2010)Global Fund To Fight AIDS, Tu…International Management: Strategy and Culture in the Emerging World (2009)International Management: Str…Rebuilding the R&D engine in big pharma. (2008)Rebuilding the R&D engine in …Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Clinical Equivalence of Gener…Projections of Global Mortality and Burden of Disease from 2002 to 2030 (2006)Projections of Global Mortali…Trade Related Aspects of Intellectual Property Rights (1996)Trade Related Aspects of Inte…Financial Protection in Health among the Elderly – A Global Stocktake (2021)Financial Protection in Healt…Statistical Methods for Meta-Analysis (1988)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Evaluating non-randomised intervention studies (2003)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study (2013)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)Modeling and Forecasting U. S. Mortality (1992)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)Counting the dead and what they died from: an assessment of the global status of cause of death data. (2005)ASSOCIATION BETWEEN SOCIAL MEDIA USE AND DEPRESSION AMONG U.S. YOUNG ADULTS (2016)Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble (2017)Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories (2018)Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. (1996)Cost of Care for Elderly Cancer Patients in the United States (2008)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Health Care Costs for Patients With Cancer at the End of Life (2012)Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care (2012)Cancer Drugs in the United States: Justum Pretium—The Just Price (2013)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration (2009)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges? (2015)What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs (2015)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Meta-analysis in clinical trials (1986)Measuring inconsistency in meta-analyses (2003)Time to retire the theory of planned behaviour (2013)Suicide and suicidal behaviour (2015)Understanding and Promoting Effective Engagement With Digital Behavior Change Interventions (2016)The impact of mergers on pharmaceutical R&D (2011)Big Pharma, little science? (2012)Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry (2018)Does progress towards universal health coverage improve population health? (2012)Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening (2013)Monitoring Progress towards Universal Health Coverage at Country and Global Levels (2014)The Economics of Patents and CopyrightGlobalisation and intellectual property in China (2003)Business strategies in the counterfeit market (2011)The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems? (2008)Global Health Actors Claim To Support Health System Strengthening—Is This Reality or Rhetoric? (2009)A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries (2010)
this work references cited by second hop

References

  • 2006Projections of Global Mortality and Burden of Disease from 2002 to 203011,372 cited
  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 2019Systematic review and meta-analysis2,659 cited
  • 2012Primary health care: Now more than ever686 cited
  • 2008Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease432 cited
  • 2011Bending the Cost Curve in Cancer Care397 cited
  • 2008Rebuilding the R&D engine in big pharma.230 cited
  • 2011Physician Perceptions About Generic Drugs193 cited
  • 2010Global Fund To Fight AIDS, Tuberculosis, And Malaria166 cited
  • 1996Trade Related Aspects of Intellectual Property Rights107 cited
  • 2009International Management: Strategy and Culture in the Emerging World79 cited
  • 2011The political economy of universal health coverage. Background paper for the global symposium on health systems research59 cited
  • 2012The Economics of Public Health Care Reform in Advanced and Emerging Economies54 cited
  • 2013Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003–1241 cited

Cited by

  • 2021

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Financial Protection in Health among the Elderly – A Global Stocktake
27 cited